APPLICATIONS PUBLISHED 6 OCTOBER 2004
Published: 1-Apr-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Anaesthetic compsns and method for their administration
Maelor Pharmaceuticals 1463486*
Liposomal delivery of vitamin E based compounds
Research Development Foundation 1463487*
Pharmaceutical compsn comprising skimmed milk powder
Alpex Pharma 1463488*
Composite dosage forms
McNeil-PPC 1463489*
Glucan-based film delivery systems
Kosmos Pharma 1463490*
Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made therefrom
Kosmos Pharma 1463491*
Adhesive and binding agent for dermal or transdermal treatment systems
Roehm 1463492*
Methods of inducing ovulation using a non-polypeptide CAMP level modulator
Applied Research Systems 1463493*
Use of polycyclic phenolic compounds for the treatment of ophthalmic diseases
MitoKor 1463494*
Agents and methods for treatment of cancer
Pharmacia 1463495*
Method for treating bronchial constriction and bronchospasm
Cellular Sciences 1463496*
Treating muscle wasting with selective androgen receptor modulators
GTX 1463497*
Compsn inhibiting matrix-metalloproteinases for the treatment of neoplastic diseases
Rath, Matthias 1463498*
Method for treating circadian rhythm disruptions
Merck 1463499*
Use of COX-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
Pharmacia & Upjohn 1463500*
Cis-imidazolines as MDM2 inhibitors
F Hoffmann-La Roche 1463501*
Broad spectrum heterocyclic substituted phenyl containing sulphonamide HIV protease inhibitors
Tibotec Pharmaceuticals 1463502*
Pharmaceutical compsn comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diseases
Merck Patent 1463503*
Compsns comprising epothilones and their use for the treatment of the carcinoid syndrome
Novartis 1463504*
3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
Abbott Laboratories 1463505*
Substituted quinazoline derivatives as inhibitors of aurora kinases
AstraZeneca 1463506*
Thienopyrimidine compounds as protein tyrosine kinase inhibitors
SmithKline Beecham 1463507*
Selective dopamine D3 receptor agonists for the treatment of sexual dysfunction
Pfizer 1463508*
Type 4 phosphodiesterase inhibitors and uses thereof
Merck Patent 1463509*
Administration of vasopeptidase inhibitors to reduce pulse pressure
Bristol-Myers Squibb 1463510*
Combination cancer therapy
Pharmacyclics 1463511*
Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
BioMarin Pharmaceuticals 1463512*
Stabilised brivudine topical formulations
Menarini Ricerche; Berlin-Chemie 1463513*
Utilisation of rutins and aescins in the treatment of ocular circulatory disturbances
Brench 1463514*
Isoflavone compsns for oral delivery
Nutraceutix 1463515*
